Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD

Antineoplastic Agents, Alkylating / therapeutic use Glycoside Hydrolases / metabolism Humans NAD / metabolism Tumor Cells, Cultured

Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
11 2020
Historique:
received: 25 02 2020
revised: 31 05 2020
accepted: 24 06 2020
pubmed: 2 7 2020
medline: 15 12 2021
entrez: 2 7 2020
Statut: ppublish

Résumé

NAD

Identifiants

DOI: 10.1158/2159-8290.CD-20-0226 PMID: 32606138 PMC: PMC7642007
pubmed: 32606138
pii: 2159-8290.CD-20-0226
doi: 10.1158/2159-8290.CD-20-0226
pmc: PMC7642007
mid: NIHMS1608505
doi:

Substances chimiques

Antineoplastic Agents, Alkylating 0
NAD 0U46U6E8UK
Glycoside Hydrolases EC 3.2.1.-
poly ADP-ribose glycohydrolase EC 3.2.1.143

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1672-1689

Subventions

Organisme : NCI NIH HHS
ID : K12 CA090354
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA165962
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA227821
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2020 American Association for Cancer Research.

Références

Nat Commun. 2019 Aug 22;10(1):3790
pubmed: 31439867
Cell Rep. 2014 Sep 25;8(6):1819-1831
pubmed: 25220464
N Engl J Med. 2016 Apr 7;374(14):1344-55
pubmed: 27050206
Neuro Oncol. 2016 Oct 1;18(suppl_5):v1-v75
pubmed: 28475809
DNA Repair (Amst). 2017 Apr;52:81-91
pubmed: 28254358
Cancer Res. 2017 Aug 1;77(15):4102-4115
pubmed: 28625978
Nat Commun. 2017 Oct 20;8(1):1067
pubmed: 29057925
Sci Transl Med. 2016 Oct 26;8(362):362ps17
pubmed: 27797957
Cancer Res. 2015 Aug 1;75(15):2999-3009
pubmed: 26045167
Science. 2016 Jun 3;352(6290):1221-5
pubmed: 27257257
Science. 2014 Jan 10;343(6167):189-193
pubmed: 24336570
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10209-14
pubmed: 24987120
J Biol Chem. 2014 Aug 22;289(34):23318-28
pubmed: 24986863
Oncol Rep. 2015 Feb;33(2):721-8
pubmed: 25504347
Sci Adv. 2019 Apr 10;5(4):eaav4340
pubmed: 30989114
Cell Death Dis. 2013 Jun 06;4:e656
pubmed: 23744356
Lancet. 2017 Oct 7;390(10103):1645-1653
pubmed: 28801186
Cancer Cell. 2019 Mar 18;35(3):519-533.e8
pubmed: 30889383
Cancer Res. 2005 Jul 15;65(14):6394-400
pubmed: 16024643
Expert Rev Anticancer Ther. 2011 Aug;11(8):1243-51
pubmed: 21916578
Cancer Res. 2017 Apr 1;77(7):1709-1718
pubmed: 28202508
Nature. 2019 Dec;576(7785):112-120
pubmed: 31748746
Neuro Oncol. 2012 Feb;14(2):132-44
pubmed: 22067563
Nat Commun. 2019 Mar 12;10(1):1182
pubmed: 30862789
Clin Cancer Res. 2019 Jul 15;25(14):4375-4387
pubmed: 30975663
Clin Cancer Res. 2016 Sep 1;22(17):4452-65
pubmed: 27076630
Cancer Res. 2019 Sep 1;79(17):4491-4502
pubmed: 31273064
Cancer Cell. 2015 Dec 14;28(6):773-784
pubmed: 26678339
Neuro Oncol. 2018 Sep 3;20(10):1300-1309
pubmed: 29452419
Sci Transl Med. 2019 Feb 13;11(479):
pubmed: 30760578
J Clin Oncol. 2014 Mar 10;32(8):783-90
pubmed: 24516018
Cancer Cell. 2018 Aug 13;34(2):186-195
pubmed: 29805076
Cell. 2018 Sep 20;175(1):101-116.e25
pubmed: 30220459
Nat Rev Cancer. 2012 Jan 12;12(2):104-20
pubmed: 22237395
Cancer. 2017 Dec 1;123(23):4535-4546
pubmed: 28980701
Cancer Cell. 2018 Jun 11;33(6):1078-1093.e12
pubmed: 29894693
Cancer Res. 2014 Sep 1;74(17):4836-44
pubmed: 25035396
Cancer Res. 2011 Mar 15;71(6):2308-17
pubmed: 21406402
Cancer Res. 2006 Apr 15;66(8):3987-91
pubmed: 16618716
Oncogene. 2019 Mar;38(12):2177-2191
pubmed: 30459355
Sci Transl Med. 2017 Feb 1;9(375):
pubmed: 28148839
Cell Mol Life Sci. 2017 Sep;74(18):3347-3362
pubmed: 28417163
Clin Cancer Res. 2020 Apr 1;26(7):1690-1699
pubmed: 31900275
Nature. 2019 May;569(7757):570-575
pubmed: 31019297
Cancer Res. 2014 Jun 15;74(12):3317-31
pubmed: 24755473
Clin Cancer Res. 2014 Jun 1;20(11):2898-909
pubmed: 24714777
Cancer Res. 2010 Nov 15;70(22):8981-7
pubmed: 21045145
Cancer Res. 2009 Apr 15;69(8):3472-81
pubmed: 19351838
Nat Commun. 2019 Jul 2;10(1):2910
pubmed: 31266951
Clin Cancer Res. 2007 Apr 1;13(7):2038-45
pubmed: 17404084
Nature. 1993 Apr 15;362(6421):652-4
pubmed: 8464518
Neuro Oncol. 2019 May 6;21(5):669-677
pubmed: 30668823
Expert Rev Mol Med. 2005 Mar 15;7(4):1-20
pubmed: 15836799
ACS Chem Biol. 2016 Nov 18;11(11):3179-3190
pubmed: 27689388
Nat Genet. 2018 Jan;50(1):62-72
pubmed: 29180699
Genes Dev. 2004 Jun 1;18(11):1272-82
pubmed: 15145826

Auteurs

Hiroaki Nagashima (H)

Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Christine K Lee (CK)

Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Kensuke Tateishi (K)

Department of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
ORCID: 0000-0001-6895-9013

Fumi Higuchi (F)

Department of Neurosurgery, Dokkyo Medical University, Mibu, Tochigi, Japan.

Megha Subramanian (M)

Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Seamus Rafferty (S)

Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Lisa Melamed (L)

Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Julie J Miller (JJ)

Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. cahill@mgh.harvard.edu hwakimoto@mgh.harvard.edu julie.miller@mgh.harvard.edu.
Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
ORCID: 0000-0002-1288-593X

Hiroaki Wakimoto (H)

Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. cahill@mgh.harvard.edu hwakimoto@mgh.harvard.edu julie.miller@mgh.harvard.edu.
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
ORCID: 0000-0001-8225-241X

Daniel P Cahill (DP)

Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. cahill@mgh.harvard.edu hwakimoto@mgh.harvard.edu julie.miller@mgh.harvard.edu.
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions toxiques › Noxas › Agents alcoylants › Antinéoplasiques alcoylants › Poly(ADP-ribose) Glycohydrolase Inhibition...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Glycosidases › Poly(ADP-ribose) Glycohydrolase Inhibition...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Poly(ADP-ribose) Glycohydrolase Inhibition...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Nucléotides › Ribonucléotides › Nucléotides adényliques › NAD › Poly(ADP-ribose) Glycohydrolase Inhibition...
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Poly(ADP-ribose) Glycohydrolase Inhibition...